About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. In 2011, the company earned the David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. In 2015, the company’s investigational Neuro-Spinal Scaffold received the 2015 Becker’s Healthcare Spine Device Award. The publicly-traded company is headquartered in Cambridge, MA. For more details, visit http://www.invivotherapeutics.com.
Management: http://www.invivotherapeutics.com/about-us/our-team/ Ongoing Human Trials: https://clinicaltrials.gov/ct2/results?term=%22invivo+therapeutics%22&Search=Search SEC Filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001292519&owner=exclude&count=40&hidefilings=0 Recent News: http://finance.yahoo.com/q/h?s=NVIV+Headlines Share Structure: http://www.otcmarkets.com/stock/NVIV/profile
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose. Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn’t a sign of endorsement. Please keep your posts on topic because your message(s) will probably be deleted when: * Posting content that's off-topic to the subject of this board; * Posting statements that don't add value to the discussion; or * When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp